The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
Abstract
Fibroblast growth factors (Fgfs) are polypeptide growth factors with diverse functions. Fgf21, a unique member of the Fgf family, is expected to function as a metabolic regulator in an endocrine manner. Hepatic Fgf21 expression was increased by fasting. The phenotypes of hepatic Fgf21 transgenic or knockdown mice and high-fat, low-carbohydrate ketogenic diet-fed mice suggests that Fgf21 stimulates lipolysis in the white adipose tissue during normal feeding and is required for ketogenesis and triglyceride clearance in the liver during fasting. However, the physiological roles of Fgf21 remain unclear. To elucidate the physiological roles of Fgf21, we generated Fgf21 knockout (KO) mice by targeted disruption. Fgf21 KO mice were viable, fertile, and seemingly normal. Food intake, oxygen consumption, and energy expenditure were also essentially unchanged in Fgf21 KO mice. However, hypertrophy of adipocytes, decreased lipolysis in adipocytes, and decreased blood nonesterified fatty acid levels were observed when Fgf21 KO mice were fed normally. In contrast, increased lipolysis in adipocytes and increased blood nonesterified fatty acid levels were observed in Fgf21 KO mice by fasting for 24 h, indicating that Fgf21 stimulates lipolysis in the white adipose tissue during feeding but inhibits it during fasting. In contrast, unexpectedly, hepatic triglyceride levels were essentially unchanged in Fgf21 KO mice. In addition, ketogenesis in Fgf21 KO mice was not impaired by fasting for 24 h. The present results indicate that Fgf21 regulates lipolysis in adipocytes in response to the metabolic state but is not required for ketogenesis and triglyceride clearance in the liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under fasted conditions, FGF21 increases hepatic gluconeogenesis, β-oxidation, and ketogenesis in mice [142,154].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [142]
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Cahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,360
Evolution of the Fgf and Fgfr gene families.
Itoh, N., & Ornitz, D. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.007 · Cited by 1,123
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Functions and regulations of fibroblast growth factor signaling during embryonic development
Thisse, B., & Thisse, C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.09.011 · Cited by 508
Cited by
Sorted by citations
Items 301–353 of 353
Ozaki‐Masuzawa, Y., Kosaka, H., Abiru, R., Toda, Y., Kawabata, K., Nagata, M., Hara, S., Konishi, M., Itoh, N., Hosono, T., et al. (2021) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbab030 · Cited by 2
Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Matikainen, N., & Söderlund, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00013-6 · Cited by 2
One-Step Production of Bioactive Proteins through Simultaneous PEGylation and Refolding
Niu, J., Zhu, Y., Song, L., Xie, Y., Zhang, Y., Wang, H., Li, X., Liu, B., Cai, L., & Huang, Z. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400314f · Cited by 2
Liver-Mediated Myocardial Protection in Experimental Myocardial Infarction
Liu, S. Q. (2013) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.s7-002 · Cited by 2
Xu, Y., Tsujimoto, K., Hashimoto, K., Kawahori, K., Hanzawa, N., Hamaguchi, M., Seki, T., Nawa, M., Ehara, T., & Kitamura, Y. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.15.14 · Cited by 2
Muhammad, M., Elwai, S., & Rahman, S. A. E. (2019) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2019.6747.1012 · Cited by 2
Lü, H., Lei, X., Guo, S., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.06.427306 · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00003-2 · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00004-4 · Cited by 2
Grandl, G., König, A., Metzger, F., Liśkiewicz, A., Hefele, T., Nason, S., Novikoff, A., Al-Refaie, N., Rahman, M. A., Khalil, A., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.05.011 · Cited by 2
Mansouri, F., Nikooie, R., Mehrtash, M., & Hamidi, M. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112864 · Cited by 2
Fgf signaling in adipocytes as a target for metabolic diseases
Ohta, H., & Itoh, N. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.11.004 · Cited by 1
Lipid Response to Amino Acid Starvation in Fat Cells: Role of FGF21
Pérez‐Martí, A., Marrero, P. F., Haro, D., & Relat, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-55387-0_15 · Cited by 1
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00001-9 · Cited by 1
Pathophysiology and Pharmacology of FGFs
Li, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816142-5.00004-7 · Cited by 1
Dey, J. H. (2010) · edoc (University of Basel) · doi:10.5451/unibas-005213494 · Cited by 2
Nelson, B. T. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Mashili, F. L. (2012) · Figshare
Metabolic signaling under nutrient deprivation
Coelho, D. S., & Luisa, A. (2012) · TDX (Tesis Doctorals en Xarxa)
Thompson, A. C. S. (2014) · ProQuest Demo Repository
Energy status and ovarian follicular development
Meng, L. (2016) · doi:10.18174/389440
Loyd, C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Lipid Response to Amino Acid Starvation in Fat Cells: Role of FGF21
Pérez‐Martí, A., Marrero, P. F., Haro, D., & Relat, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-40007-5_15-1
Neuroprotective genes activated in the liver in response to experimental stroke
Liu, S. Q., Shah, S., & Wu, Y. (2017) · International Conference on Computational Intelligence and Applications (ICCIA) · doi:10.1109/ciapp.2017.8167245
The Role Of Crebh In Hepatic Energy Regulation Under Metabolic Stress
Mendez, R. (2015) · Human Biology
Ivanova, K. (2018) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2018-3-1-145-108-112
Rôle des hépatokines dans le dialogue inter-organes en physiologie et physiopathologie
Pacheco, A., & Postic, C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.04.008
Garza, M., & Montserrat, Ú. (2020)
Means, A. R. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13865958.15303059
Mehmood, R. (2011) · doi:10.3998/panc.2011.35
CO as a Protective Mediator of Liver Injury
Joe, Y., Park, J., Do, M., Ryter, S. W., Surh, Y., Kim, U., & Chung, A. H. T. (2022) · doi:10.1002/9781119783435.ch22
Signaling pathway and pharmacology
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00005-6
Lü, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881329
Trapali, M., Καρκαλούσος, Π., Dogkas, N., & Karikas, G. A. (2025) · Review of Clinical Pharmacology and Pharmacokinetics - International Edition · doi:10.61873/bbdf1129
Zheng, L., Sasaki, T., Ni, L., Takahashi, Y., Yamauchi, Y., Shimizu, M., & Sato, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.18.638653
Insulin-sensitizing effects of fibroblast growth factor-21 in underfed sheep
dos Santos, A. C. R., McGuckin, M. M., Giesy, S. L., & Boisclair, Y. R. (2025) · Journal of Animal Science · doi:10.1093/jas/skaf217
Hu, J., Xu, Y., Zhou, D., Chen, K., Jiang, J., Lin, M., Chen, W., Wu, J., Jiang, H., Zhu, M., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5365566
Bruse, J., Marbach, C., Polizzi, A., Landré, T., Salvi, J., Alquier‐Bacquie, V., Shiou-Ping, C., Huillet, M., Rives, C., Martin, C. M. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.22.683899
Lu, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881323
Lu, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881326
Lu, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881335
Lu, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881317
Lu, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881332
Lu, H., Lei, X., Winkler, R., John, S., Kumar, D., Li, W., & Alnouti, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19881320
Zhang, Y., Liu, D., Lu, Y., Kang, P., Liu, X., Wang, Q., Chen, A., Cheng, D., Wu, L., Li, Q., et al. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0814
Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
Ghanem, M. (2023) · theses.fr (ABES) · doi:10.70675/fd0d64f8zacf4z4856z9b1az66d4df37a332
Bruse, J., Marbach, C., Polizzi, A., Landré, T., Salvi, J., Alquier‐Bacquie, V., Chen, S.-P., Huillet, M., Rives, C., Céline, M., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00790-9
Masuda, Y., Nakayama, Y., Shimizu, R., Hasegawa, H., & Konishi, M. (2026) · Science Advances · doi:10.1126/sciadv.aee9999
Advances in FGF/FGFR Signaling: Implications for Disease and Therapy
Song, M., Liu, X., Xiao, Y., Li, Y., & Zhao, H. (2026) · MedComm · doi:10.1002/mco2.70922
Akcan, M., Jeromson, S., Baranowski, B. J., Bellucci, A., Trang, S., Eisner, K., Babicki-Moore, A., Alfares, H., Arbeau, M., Medak, K., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202602558r
Kon, M., Ato, S., & Matsuo, K. (2026) · International Journal of Sports Medicine · doi:10.1055/a-2975-4387
Metadata
- Authors
- Hotta, Y., Nakamura, H., Konishi, M., Murata, Y., Takagi, H., Matsumura, S., Inoue, K., Fushiki, T., & Itoh, N.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Konishi, Morichika
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-07-09
- Volume
- 150
- Issue
- 10
- Pages
- 4625-4633
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2042911346
- Cited by
- 352
- References
- 25
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 20 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 18 · 2019: 25 · 2018: 27 · 2017: 28 · 2016: 27 · 2015: 30 · 2014: 24 · 2013: 23 · 2012: 30
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- FGF21, lipolysis, white adipose tissue, ketogenesis, triglyceride clearance, liver, fasting, free fatty acids, adipocyte hypertrophy, FGF21 knockout mice, energy metabolism, ketogenic diet
- MeSH terms
- Animals, Fasting, Fibroblast Growth Factors, Glycogen, Ketone Bodies, Lipolysis, Liver, Male, Mice, Inbred C57BL, Phenotype, Triglycerides, Gene Expression, Adipocytes, Mice, Knockout, Mice, Adipose Tissue, White, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review